[ad_1] OSLO, Norway, Oct. 10, 2024 /PRNewswire/ — Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of […]
Tag: Biotechnology
Conference call interim report
[ad_1] GOTHENBURG, Sweden, Oct. 10, 2024 /PRNewswire/ — Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2024. The presentation will be held in English. Time: Thursday 24 October, […]
Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause
[ad_1] TOKYO, Oct. 10, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced that VEOZA™ (fezolinetant)*, its first-in-class treatment for moderate to severe vasomotor symptoms (VMS) associated with menopause, will be […]
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
[ad_1] CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 9, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on […]
CZI, State and City Leaders Launch Chan Zuckerberg Biohub New York
[ad_1] CZ Biohub New York is catalyzing collaboration among scientists in the New York area from Columbia University, The Rockefeller University, and Yale University. NEW YORK, Oct. 9, 2024 /PRNewswire/ — Today, leadership from Chan Zuckerberg […]
